India, Sept. 26 -- US President Donald Trump on Thursday announced a 100 per cent tariff on imports of branded or patented pharmaceutical products from October 1, a move that could have major repercussions for key Indian drugmakers.

"Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be defined as, 'breaking ground' and/or 'under construction,'" Trump wrote in a post on Truth Social.

The announcement extends beyond pharmaceuticals. Donald Trump said 50 per cent import taxes will be levied on kitchen cabinets, 30 percent on upholstered furniture, and 25 per cent on heavy trucks...